Survival Associations Using Perfusion and Diffusion Magnetic Resonance Imaging in Patients With Histologic and Genetic Defined Diffuse Glioma World Health Organization Grades II and III

Objective According to the new World Health Organization 2016 classification for tumors of the central nervous system, 1p/19q codeletion defines the genetic hallmark that differentiates oligodendrogliomas from diffuse astrocytomas. The aim of our study was to evaluate whether relative cerebral blood volume (rCBV) and apparent diffusion coefficient (ADC) histogram analysis can stratify survival in adult patients with genetic defined diffuse glioma grades II and III. Methods Sixty-seven patients with untreated diffuse gliomas World Health Organization grades II and III and known 1p/19q codeletion status were included retrospectively and analyzed using ADC and rCBV maps based on whole-tumor volume histograms. Overall survival and progression-free survival (PFS) were analyzed by using Kaplan-Meier and Cox survival analyses adjusted for known survival predictors. Results Significant longer PFS was associated with homogeneous rCBV distribution–higher rCBVpeak (median, 37 vs 26 months; hazard ratio [HR], 3.2; P = 0.02) in patients with astrocytomas, and heterogeneous rCBV distribution–lower rCBVpeak (median, 46 vs 37 months; HR, 5.3; P
Source: Journal of Computer Assisted Tomography - Category: Radiology Tags: Neuroradiology Source Type: research

Related Links:

Authors: Zhu J, Zhao YP, Zhang YQ Abstract Objectives: FOSL1 is overexpressed in multiple cancers including malignant glioma and contributes to different cellular processes. However, little attention has been paid to the lower grade glioma (LGG).Methods: Cox coefficients were examined to compare FOSL1 expression among different tumors types using OncoLnc. The UCSC Xena browser was used to generate Kaplan-Meier survival curves and explore the association between FOSL1 expression and overall survival (OS) in TCGA-LGG and subgroups.Results: FOSL1 expression in LGG was ranked first among 21 different cancers. LGG with ...
Source: Neurological Research - Category: Neurology Tags: Neurol Res Source Type: research
Conditions:   Glioblastoma Multiforme;   Astrocytoma;   Gliomas, Malignant Interventions:   Biological: Toca 511 vector;   Drug: Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine Sponsor:   Tocagen Inc. Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study analyzedIDH,ATRX, andTERT promoter mutations, and the correlation between them. Immortalized cells overcome the telomere-related crisis by activating telomerase or ALT. In glioma, telomerase is mainly activated byTERT promoter mutation, while ALT is usually associated withATRX mutation. Although the mechanism of howATRX mutation induces ALT remains unclear, ATRX loss alone is believed to be insufficient to induce ALT. Treatments targeting telomere maintenance are promising.
Source: Brain Tumor Pathology - Category: Neurology Source Type: research
CONCLUSION: We found that the 2016 WHO classification of central nervous system tumors had superior ability to predict survival in cases of anaplastic glioma, as compared to the 2007 WHO classification.
. PMID: 32194024 [PubMed - as supplied by publisher]
Source: Clinical Neuropathology - Category: Pathology Authors: Tags: Clin Neuropathol Source Type: research
In this study we assessed whether gliomas could be subdivided into different molecular subtypes by immunohistochemistry (IHC) reminiscent of those first described by Verhaak et al. in 2010 (classical, proneural, mesenchymal and neural). We also evaluated the prognostic significance of single molecular factors and searched for significant correlations between markers. In this study, we included 146 patients with glioblastomas (GBMs) and 26 with diffuse astrocytomas (DAs). The glioma samples were tested for PDGFRA, IDH1 R132H, CD44, p53, Ki-67, p21 and p27 expression. We found that gliomas could be subdivided into molecular ...
Source: Polish Journal of Pathology - Category: Pathology Tags: Pol J Pathol Source Type: research
Conditions:   Astrocytoma, Grade II;   Astrocytoma, Grade III;   Oligodendroglioma;   Oligodendroglioma, Anaplastic Intervention:   Sponsors:   Erasmus Medical Center;   HollandPTC;   Amsterdam University Medical Center;   Leiden University Medical Center;   Delft University of Technology;   Medical Center Haaglanden Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We present a summary of the study characteristics and QUADAS-2 results, and rate studies as good quality when they have low risk of bias in the domains of reference standard of tissue diagnosis and flow and timing between MR perfusion and tissue diagnosis.In the quantitative analysis, LGGs were considered disease positive, while HGGs were disease negative. The sensitivity refers to the proportion of LGGs detected by MR perfusion, and specificity as the proportion of detected HGGs. We constructed two-by-two tables with true positives and false negatives as the number of correctly and incorrectly diagnosed LGG, respectively,...
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research
CONCLUSIONS:ASL is an emerging MRI technique that provides quantitative CBF measurements without contrast administration, ideal for following patients diagnosed with high grade glioma undergoing treatment. It may be helpful in the setting of a patient with suspicious progression on contrast MRI and fluid attenuated inversion recovery (FLAIR) sequences and no neurological progression, for whom treatment decisions need to be made.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Tags: NEURO-IMAGING Source Type: research
More News: Astrocytoma | Brain | Brain Tumor | Computers | Genetics | Glioma | International Medicine & Public Health | MRI Scan | Neurology | Perfusion | Study | WHO